Development and Validation of a Quantitative NMR Method for the Determination of the Commercial Tablet Formulation of Sulfasalazine

被引:4
|
作者
Su, Feng [1 ,2 ]
Sun, Zi-qing [1 ,2 ]
Liang, Xian-Rui [1 ,2 ]
机构
[1] Zhejiang Univ Technol, Coll Pharmaceut Sci, Minist Educ, Key Lab Green Pharmaceut Technol & Related Equipm, Hangzhou 310014, Zhejiang, Peoples R China
[2] Zhejiang Univ Technol, Collaborat Innovat Ctr Yangtze River Delta Reg Gr, Natl Engn Res Ctr Proc Dev Act Pharmaceut Ingredi, Hangzhou 310014, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
NMR; qNMR; sulfasalazine; method validation; commercial tablet formulation; pharmaceutical analysis; SPECTROSCOPY; SPECTROMETRY; H-1;
D O I
10.2174/1573412913666170707113548
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Quantitative NMR spectroscopy (qNMR) is a rapid, simple and efficient method for the assay of sulfasalazine (SSZ) in commercial tablet formulation. Materials and Methods: The qNMR method was demonstrated using maleic acid as an internal standard and DMSO-d(6) as a solvent. The characteristic signals of SSZ at delta 8.36 ppm and maleic acid at delta 6.28 ppm were quantified. The reliability of the quantification method had been implemented successfully in validated experiments including specificity and selectivity, linearity, recovery, precision concentration rang, limit of detection (LOD), limit of quantification (LOQ), stability and robustness. Conclusion: The method was found to be liner (R-2 = 0.9991) from 8.62 to 20.14 mg/0.6 mL DMSO-d(6) in the drug concentration range. The maximum relative standard deviation (RSD) of recovery and precision were tested to be 0.59% and 0.65%, respectively. The LOD and LOQ were determined to be 0.02, 0.07 mg/mL, respectively. The RSD of stability was 0.05%. The robustness was demonstrated by changing four different parameters with the maximum difference less than 0.9%. In addition, the result of qNMR showed in good agreement with the HPLC and UV methods. Based on the experiments, the developed method was successfully applied to the determination of SSZ in commercial tablet.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [41] Development and Validation of an HPLC Method for the Determination of Meloxicam and Pantoprazole in a Combined Formulation
    Ahmad, Raneem
    Hailat, Mohammad
    Zakaraya, Zainab
    Al Meanazel, Osaid
    Abu Dayyih, Wael
    ANALYTICA, 2022, 3 (02): : 161 - 177
  • [42] Design of experiment avenue for development and validation of RP-HPLC-PDA method for determination of apremilast in bulk and in in-house tablet formulation
    Chaudhari, Suraj R.
    Shirkhedkar, Atul A.
    JOURNAL OF ANALYTICAL SCIENCE AND TECHNOLOGY, 2019, 10 (1)
  • [43] Design of experiment avenue for development and validation of RP-HPLC-PDA method for determination of apremilast in bulk and in in-house tablet formulation
    Suraj R. Chaudhari
    Atul A. Shirkhedkar
    Journal of Analytical Science and Technology, 10
  • [44] High performance thin layer chromatography (HPTLC) method development and validation for the simultaneous determination of paracetamol, caffeine, chlorpheniramine and phenylepherine in tablet formulation
    Arage, Almaz
    Layloff, Thomas
    Hymete, Ariaya
    Ashenef, Ayenew
    ACTA CHROMATOGRAPHICA, 2023, 35 (02) : 170 - 178
  • [45] Development and validation of a novel RP-HPLC method for simultaneous determination of paracetamol, phenylephrine hydrochloride, caffeine, cetirizine and nimesulide in tablet formulation
    Dewani, A. P.
    Dabhade, S. M.
    Bakal, R. L.
    Gadewar, C. K.
    Chandewar, A. V.
    Patra, S.
    ARABIAN JOURNAL OF CHEMISTRY, 2015, 8 (04) : 591 - 598
  • [46] Development and validation of a stability-indicating column high-performance liquid chromatographic assay method for determination of nebivolol in tablet formulation
    Kachhadia, Pankaj K.
    Doshi, Ashish S.
    Joshi, Hitendra S.
    JOURNAL OF AOAC INTERNATIONAL, 2008, 91 (03) : 557 - 561
  • [47] Quantitative 31P-NMR for Purity Determination of Sofosbuvir and Method Validation
    Uchiyama, Nahoko
    Kiyota, Kohei
    Hosoe, Junko
    Komatsu, Takanori
    Sugimoto, Naoki
    Ishizuki, Kyoko
    Koide, Tatsuo
    Murabayashi, Mika
    Kobayashi, Kengo
    Fujimine, Yoshinori
    Yokose, Toshiyuki
    Ofuji, Katsuya
    Shimizu, Hitoshi
    Hasebe, Takashi
    Asai, Yumi
    Ena, Eri
    Kikuchi, Junko
    Fujita, Kazuhiro
    Makino, Yoshinobu
    Iwamoto, Yoshiaki
    Miura, Toru
    Muto, Yasuhiro
    Asakura, Katsuo
    Suematsu, Takako
    Muto, Hitomi
    Kohama, Ai
    Goto, Takashi
    Yasuda, Masu
    Ueda, Tomohiko
    Goda, Yukihiro
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2022, 70 (12) : 892 - 900
  • [48] Development and Validation of a Stability-Indicating LC Method for Determination of Ebastine in Tablet and Syrup
    Arend, Marcela Z.
    Cardoso, Simone G.
    Hurtado, Felipe K.
    Ravanello, Aline
    Lanzanova, Fibele A.
    Rolim, Clarice M. B.
    CHROMATOGRAPHIA, 2009, 69 : 195 - 199
  • [49] Development and Validation of a Stability-Indicating LC Method for Determination of Ebastine in Tablet and Syrup
    Marcela Z. Arend
    Simone G. Cardoso
    Felipe K. Hurtado
    Aline Ravanello
    Fibele A. Lanzanova
    Clarice M. B. Rolim
    Chromatographia, 2009, 69 : 195 - 199
  • [50] DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE DETERMINATION OF DASATINIB IN TABLET DOSAGE FORM
    Sankar, Panchumarthy Ravi
    Anusha, Saranu
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (10): : 4531 - 4537